Pfizer's Says Company "Very" Big Balance Sheet for Deals
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
Saving cash on a tight budget is possible with the right strategies. Discover effective tips to stretch your dollars further.
22,187 articlesPfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
Two pharma giants flashed a golden cross this month, but the stories behind AbbVie and Baxter diverge sharply for inc...
As the EV wave grows, two names stand out: Lucid and NIO. This guide weighs their momentum, finances, and risk, helpi...
When a big fund buys in after a sharp drop, it sends a message about confidence and risk. This piece breaks down what...
Investing in today’s AI-powered era means spotting durable winners. This guide explains how to identify a meet monste...
Meta Platforms is catching the eye of value-focused investors. This guide breaks down why meta stock could most under...
Four tech giants just reported earnings, but which one unlocks the best risk-adjusted upside for investors? This guid...
Investors are weighing growth, profitability, and risk after the newest earnings release. Here’s a practical, plain-l...
A new wave of headlines around Nebius stock is stirring debate among investors. This guide breaks down what the news ...
An activist investor’s purchase often signals interest in a company’s next chapter. Read how Edward Garden’s stake co...
The Macy's 2026 earnings call will reveal how a storied department store navigates digital growth, store productivity...
A recent insider move at Precigen has many investors asking if a CFO’s share sale signals trouble. This deep-dive bre...